• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Exploring Genetic Testing for Rare Disorders of Obesity: Experience and Perspectives of Pediatric Weight Management Providers.探索肥胖罕见疾病的基因检测:儿科体重管理提供者的经验和观点。
Child Obes. 2024 Oct;20(7):451-458. doi: 10.1089/chi.2023.0125. Epub 2024 Jan 8.
2
Interventions for providers to promote a patient-centred approach in clinical consultations.为医疗服务提供者提供的干预措施,以促进临床会诊中以患者为中心的方法。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD003267. doi: 10.1002/14651858.CD003267.pub2.
3
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
4
A Shadow of Doubt: Is There Implicit Bias Among Orthopaedic Surgery Faculty and Residents Regarding Race and Gender?疑虑重重:骨科手术教员和住院医师在种族和性别方面是否存在隐性偏见?
Clin Orthop Relat Res. 2024 Jul 1;482(7):1145-1155. doi: 10.1097/CORR.0000000000002933. Epub 2024 Jan 12.
5
Pulmonologists' Attitudes and Role in Precision Medicine Biomarker Testing for Non-Small Cell Lung Cancer.肺科医生在非小细胞肺癌精准医学生物标志物检测中的态度和作用。
Chest. 2024 Nov;166(5):1229-1238. doi: 10.1016/j.chest.2024.06.001. Epub 2024 Jun 19.
6
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
7
Continuing education meetings and workshops: effects on professional practice and healthcare outcomes.继续教育会议和研讨会:对专业实践和医疗保健结果的影响。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD003030. doi: 10.1002/14651858.CD003030.pub3.
8
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
9
Can We Enhance Shared Decision-making for Periacetabular Osteotomy Surgery? A Qualitative Study of Patient Experiences.我们能否加强髋臼周围截骨术的共同决策?一项关于患者体验的定性研究。
Clin Orthop Relat Res. 2025 Jan 1;483(1):120-136. doi: 10.1097/CORR.0000000000003198. Epub 2024 Jul 23.
10
Potential barriers to implementation of next-generation sequencing in cancer management: a U.S. Physician-based survey.癌症管理中实施下一代测序的潜在障碍:一项基于美国医生的调查。
Future Oncol. 2025 Jan;21(2):231-239. doi: 10.1080/14796694.2024.2430725. Epub 2024 Nov 28.

引用本文的文献

1
Obesity: pathophysiology and therapeutic interventions.肥胖症:病理生理学与治疗干预措施
Mol Biomed. 2025 Apr 25;6(1):25. doi: 10.1186/s43556-025-00264-9.
2
Molecular Genetic Architecture of Morbid Obesity in Russian Children.俄罗斯儿童病态肥胖的分子遗传结构
Biomedicines. 2025 Mar 20;13(3):756. doi: 10.3390/biomedicines13030756.
3
Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity.肥胖个体中罕见基因变异、基因检测和基因治疗的最新进展。
Curr Obes Rep. 2024 Sep;13(3):626-641. doi: 10.1007/s13679-024-00567-y. Epub 2024 Jun 1.

本文引用的文献

1
Prevalence of genetic causes of obesity in clinical practice.临床实践中肥胖症遗传原因的患病率。
Obes Sci Pract. 2023 May 26;9(5):508-515. doi: 10.1002/osp4.671. eCollection 2023 Oct.
2
Current Treatments for Patients with Genetic Obesity.遗传性肥胖症患者的当前治疗方法。
J Clin Res Pediatr Endocrinol. 2023 May 29;15(2):108-119. doi: 10.4274/jcrpe.galenos.2023.2023-3-2. Epub 2023 May 16.
3
Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.儿童和青少年肥胖评估与治疗临床实践指南
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2022-060640.
4
Ethical Considerations in Precision Medicine and Genetic Testing in Internal Medicine Practice: A Position Paper From the American College of Physicians.精准医学和内科实践中的遗传检测中的伦理考量:美国医师学院的立场文件。
Ann Intern Med. 2022 Sep;175(9):1322-1323. doi: 10.7326/M22-0743. Epub 2022 Jul 26.
5
Testing for rare genetic causes of obesity: findings and experiences from a pediatric weight management program.检测肥胖的罕见遗传病因:儿科体重管理项目的发现与经验。
Int J Obes (Lond). 2022 Aug;46(8):1493-1501. doi: 10.1038/s41366-022-01139-7. Epub 2022 May 13.
6
Patients' and professionals' views related to ethical issues in precision medicine: a mixed research synthesis.患者和专业人员对精准医学中伦理问题的看法:一项混合研究综述。
BMC Med Ethics. 2021 Aug 31;22(1):116. doi: 10.1186/s12910-021-00682-8.
7
Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics.非遗传学专业的儿科医疗人员对意义未明的变异(VUS)基因检测结果的理解与解读。
J Genet Couns. 2021 Dec;30(6):1559-1569. doi: 10.1002/jgc4.1422. Epub 2021 May 9.
8
Ethical, Legal, and Social Issues (ELSI) in Clinical Genetics Research.临床遗传学研究中的伦理、法律和社会问题 (ELSI)。
Methods Mol Biol. 2021;2249:65-82. doi: 10.1007/978-1-0716-1138-8_5.
9
Call for improvement in medical school training in genetics: results of a national survey.呼吁改进医学院遗传学培训:全国调查结果。
Genet Med. 2021 Jun;23(6):1151-1157. doi: 10.1038/s41436-021-01100-5. Epub 2021 Feb 12.
10
Precision Medicine and Obesity.精准医学与肥胖
Gastroenterol Clin North Am. 2021 Mar;50(1):127-139. doi: 10.1016/j.gtc.2020.10.005. Epub 2021 Jan 5.

探索肥胖罕见疾病的基因检测:儿科体重管理提供者的经验和观点。

Exploring Genetic Testing for Rare Disorders of Obesity: Experience and Perspectives of Pediatric Weight Management Providers.

机构信息

School of Nursing, College of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.

Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Child Obes. 2024 Oct;20(7):451-458. doi: 10.1089/chi.2023.0125. Epub 2024 Jan 8.

DOI:10.1089/chi.2023.0125
PMID:38227789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11535453/
Abstract

This study describes experiences and perspectives of pediatric weight management (PWM) providers on the implementation of genetic testing for rare causes of obesity. Purposive and snowball sampling recruited PWM providers via email to complete a 23-question survey with multiple choice and open-ended questions. Analyses include descriptive statistics, Fisher's exact test, one-way ANOVA with Tukey's test, and qualitative analysis. Of the 55 respondents, 80% reported ordering genetic testing. Respondents were primarily physicians (82.8%) in practice for 11-20 years (42%), identified as female (80%), White (76.4%), and non-Hispanic (92.7%) and provided PWM care 1-4 half day sessions per week. Frequently reported patient characteristics that prompted testing did not vary by provider years of experience (YOE). These included obesity onset before age 6, hyperphagia, dysmorphic facies, and developmental delays. The number of patient characteristics that prompted testing varied by YOE ( = 0.03); respondents with 6-10 YOE indicated more patient characteristics than respondents with >20 YOE (mean 10.3 vs. mean 6.2). The reported primary benefit of testing was health information for patients/families; the primary drawback was the high number of indeterminate tests. Ethical concerns expressed were fear of increasing weight stigma, discrimination, and impact on insurance coverage. Respondents (42%) desired training and guidance on interpreting results and counseling patients and families. Most PWM providers reported genetic testing as an option for patient management. Provider training in genetics/genomics and research into provider and family attitudes on the genetics of obesity and the value of genetic testing are next steps to consider.

摘要

本研究描述了儿科体重管理(PWM)提供者在实施罕见肥胖病因的基因检测方面的经验和观点。通过电子邮件有针对性和滚雪球抽样招募 PWM 提供者,让他们完成一份包含 23 个多项选择题和开放式问题的调查问卷。分析包括描述性统计、Fisher 确切检验、单向方差分析和 Tukey 检验,以及定性分析。在 55 名受访者中,80%报告了基因检测的订单。受访者主要是从业 11-20 年的医生(82.8%)(42%),性别为女性(80%),白种人(76.4%),非西班牙裔(92.7%),每周提供 1-4 次半天的 PWM 护理。经常报告的促使进行检测的患者特征不因提供者的从业年限而异。这些特征包括 6 岁以前发病的肥胖、暴食症、畸形面容和发育迟缓。促使进行检测的患者特征数量因从业年限而异( = 0.03);从业 6-10 年的受访者表示比从业超过 20 年的受访者有更多的患者特征(平均 10.3 比平均 6.2)。测试的主要好处报告为患者/家庭的健康信息;主要缺点是不确定测试数量过多。表达的伦理问题包括担心增加体重耻辱感、歧视和对保险覆盖范围的影响。受访者(42%)希望在解读结果和咨询患者和家庭方面得到培训和指导。大多数 PWM 提供者将基因检测作为患者管理的一种选择。下一步是考虑在遗传学/基因组学方面对提供者进行培训,以及研究提供者和家庭对肥胖遗传学和基因检测价值的态度。